CORRECTION: Actavis To Halt Production At 3 Plants
Generic-drug maker Actavis Group has reached an agreement with the U.S. Food and Drug Administration to halt production at three of its U.S. subsidiary's plants until the facilities are upgraded to...To view the full article, register now.
Already a subscriber? Click here to view full article